Stephen Phillips
Overview
Explore the profile of Stephen Phillips including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phillips S, Feola A, Solomon J, Cardelle L, Douglass A, Bales K, et al.
Mol Vis
. 2025 Feb;
30:239-259.
PMID: 39959182
While the high-dose streptozotocin (STZ; 100 mg/kg) rodent model is the gold standard in modeling Type I diabetes, models for Type II diabetes are needed for this more common form...
2.
Kim D, Singh N, Catanese L, Yu A, Demchuk A, Lloret-Villas M, et al.
Stroke
. 2024 Jan;
55(2):288-295.
PMID: 38174568
Background: Understanding sex differences in stroke care is important in reducing potential disparities. Our objective was to explore sex differences in workflow efficiency, treatment efficacy, and safety in the AcT...
3.
Bala F, Almekhlafi M, Singh N, Alhabli I, Ademola A, Coutts S, et al.
Int J Stroke
. 2023 Sep;
19(3):322-330.
PMID: 37731173
Background: Carotid tandem lesions ((TL) ⩾70% stenosis or occlusion) account for 15-20% of acute stroke with large vessel occlusion. Aims: We investigated the safety and efficacy of intravenous tenecteplase (0.25 ...
4.
Bala F, Singh N, Buck B, Ademola A, Coutts S, Deschaintre Y, et al.
JAMA Neurol
. 2023 Jul;
80(8):824-832.
PMID: 37428494
Importance: It is unknown whether intravenous thrombolysis using tenecteplase is noninferior or preferable compared with alteplase for patients with acute ischemic stroke. Objective: To examine the safety and efficacy of...
5.
Phillips S
Hum Rights Rev
. 2023 Jun;
:1-21.
PMID: 37362819
This article examines the impact of law and policy changes enacted in times of crisis on asylum seekers, and considers the extent to which considerations of vulnerability have played a...
6.
Menon B, Buck B, Singh N, Deschaintre Y, Almekhlafi M, Coutts S, et al.
Lancet
. 2022 Jul;
400(10347):161-169.
PMID: 35779553
Background: Intravenous thrombolysis with alteplase bolus followed by infusion is a global standard of care for patients with acute ischaemic stroke. We aimed to determine whether tenecteplase given as a...
7.
Neal J, Hu S, Reid J, Matheson K, Gubitz G, Simpkin W, et al.
Can J Neurol Sci
. 2022 Jun;
50(4):535-541.
PMID: 35722755
Background: Mortality remains a substantial problem after acute ischemic stroke, despite advances in acute stroke treatment over the past three decades. Mortality is particularly high among patients with Total Anterior...
8.
Meitner S, Phillips S, Carneiro L, Caton J, Javed F, Feng C, et al.
Int J Oral Maxillofac Implants
. 2022 Mar;
37(1):104-113.
PMID: 35235628
Purpose: Implant surgical guides are often fabricated using CBCT technology. In this study, an alternative technique is proposed. The aim of this in vitro study was to compare the accuracy...
9.
Woodhouse L, Appleton J, Scutt P, Everton L, Wilkinson G, Caso V, et al.
EClinicalMedicine
. 2022 Feb;
44:101274.
PMID: 35112073
Background: It is not known whether to continue or temporarily stop existing antihypertensive drugs in patients with acute stroke. Methods: We performed a prospective subgroup analysis of patients enrolled into...
10.
MacKay-Lyons M, Gubitz G, Phillips S, Giacomantonio N, Firth W, Thompson K, et al.
Neurorehabil Neural Repair
. 2021 Nov;
36(2):119-130.
PMID: 34788569
Background: Non-disabling stroke (NDS) and transient ischemic attack (TIA) herald the possibility of future, more debilitating vascular events. Evidence is conflicting about potency of exercise and education in reducing risk...